Advertisement
Screener

Stock Idea: Buy Ratings, Foreign Stocks, August 2026

Buy analyst ratings: Foreign

2,752 dated buy ratings on 290 Foreign stocks (depositary receipts, New York registry shares and stocks traded over the counter), newest first. The firms' own words in this tab: Buy, Outperform, Overweight. Each row is as the research firm published it in its public rating disclosure. Not investment advice and not a consensus.

  • 2026-08-26: Stock BZ; Price Target $20.00; Price When Rated $16.29; Upside / Downside +22.77%.
  • 2026-08-26: Stock VIPS; Price Target $19.00; Price When Rated $14.32; Upside / Downside +32.68%.
  • 2026-08-20: Stock BABA; Price Target $200.00; Price When Rated $128.90; Upside / Downside +55.16%.
  • 2026-08-20: Stock BABAF; Price Target $200.00; Price When Rated $128.90; Upside / Downside +55.16%.
DateStockPrice TargetPrice When RatedUpside / DownsideAnalystFirmRating
2026-08-26BZ
Kanzhun Ltd
$20.00$16.29+22.77%Jiong ShaoBarclaysOverweight
2026-08-26VIPS
Vipshop Holdings Ltd
$19.00$14.32+32.68%Jiong Shao
Lian Xiu (Roger) Duan
BarclaysOverweight
2026-08-20BABA
Alibaba Group Holding Ltd
$200.00$128.90+55.16%Jiong ShaoBarclaysOverweight
2026-08-20BABAF
Alibaba Group Holding Ltd
$200.00$128.90+55.16%Jiong ShaoBarclaysOverweight
2026-08-20BBAAY
Alibaba Group Holding Ltd
$200.00$128.90+55.16%Jiong ShaoBarclaysOverweight
2026-08-17ARGX
ARGENX SE
$1,050.00$851.29+23.34%David NierengartenWedbush SecuritiesOutperform
2026-08-17ASND
Ascendis Pharma A/S
$327.00$248.50+31.59%Yun ZhongWedbush SecuritiesOutperform
2026-08-17CRTO
Criteo S.A.
$30.00$19.00+57.89%Ygal ArounianWedbush SecuritiesOutperform
2026-08-17DDI
DoubleDown Interactive Co., Ltd.
$15.00$12.92+16.10%Alicia ReeseWedbush SecuritiesOutperform
2026-08-17SE
Sea Ltd
$120.00$121.94-1.59%Research DepartmentWedbush SecuritiesOutperform
2026-08-17TLPPF
Telix Pharmaceuticals Ltd
$22.00$11.82+86.13%David NierengartenWedbush SecuritiesOutperform
2026-08-16MNSO
MINISO Group Holding Ltd
$19.84$11.80+68.14%Not namedUBS Investment BankBuy
2026-08-16MSOGF
MINISO Group Holding Ltd
$19.84$11.80+68.14%Not namedUBS Investment BankBuy
2026-08-13ASND
Ascendis Pharma A/S
$329.00$255.46+28.79%Eliana MerleBarclaysOverweight
2026-08-12SE
Sea Ltd
$156.00$131.51+18.62%Jiong ShaoBarclaysOverweight
2026-08-11LEGN
Legend Biotech Corp
$78.00$20.66+277.54%Etzer DaroutBarclaysOverweight
2026-08-11TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$42.00$36.14+16.21%Glen SantangeloBarclaysOverweight
2026-08-11TEVJF
TEVA PHARMACEUTICAL INDUSTRIES LTD
$42.00$36.14+16.21%Glen SantangeloBarclaysOverweight
2026-08-10ELVR
Elevra Lithium Ltd
$11.70$8.52+37.32%Not namedUBS Investment BankBuy
2026-08-10JHIUF
James Hardie Industries plc
$35.00$30.23+15.78%Matthew BouleyBarclaysOverweight
2026-08-10SYAXF
Elevra Lithium Ltd
$11.70$8.52+37.32%Not namedUBS Investment BankBuy
2026-08-09TNRSF
TENARIS SA
$80.00$53.04+50.83%J. David AndersonBarclaysOverweight
2026-08-09TS
TENARIS SA
$80.00$53.04+50.83%J. David AndersonBarclaysOverweight
2026-08-05BEIGF
BeOne Medicines Ltd.
$407.00$323.01+26.00%Etzer DaroutBarclaysOverweight
2026-08-05CBDY
Target Group Inc.
$166.00$147.70+12.39%Not namedUBS Investment BankBuy
2026-08-05ONC
BeOne Medicines Ltd.
$407.00$323.01+26.00%Etzer DaroutBarclaysOverweight
2026-08-04PUK
PRUDENTIAL PLC
$1,515.00$1,095.00+38.36%Not namedUBS Investment BankBuy
2026-08-04PUKPF
PRUDENTIAL PLC
$1,515.00$1,095.00+38.36%Not namedUBS Investment BankBuy
2026-08-03BPOPO
POPULAR, INC.
$200.00$175.21+14.15%Jared ShawBarclaysOverweight
2026-08-03FINCF
Fortis Inc.
$60.00$57.00+5.26%Michael Lonegan
Nicholas Campanella
BarclaysOverweight
2026-08-03FORFF
Fortis Inc.
$60.00$57.00+5.26%Michael Lonegan
Nicholas Campanella
BarclaysOverweight
2026-08-03FRTJF
Fortis Inc.
$60.00$57.00+5.26%Michael Lonegan
Nicholas Campanella
BarclaysOverweight
2026-08-03FRTSF
Fortis Inc.
$60.00$57.00+5.26%Michael Lonegan
Nicholas Campanella
BarclaysOverweight
2026-08-03FTPSF
Fortis Inc.
$60.00$57.00+5.26%Michael Lonegan
Nicholas Campanella
BarclaysOverweight
2026-08-03FTRSF
Fortis Inc.
$60.00$57.00+5.26%Michael Lonegan
Nicholas Campanella
BarclaysOverweight